Introdução: Feocromocitomas são tumores originários de células cromafins do sistema simpato-adrenal. As suas manifestações clínicas são múltiplas e diversificadas, função do perfil secretório variável de múltiplos compostos, incluindo catecolaminas, neuropéptidos e outros compostos vasoactivos. A Neurofibromatose 1 (D de von Recklinghausen), a mais prevalente das variantes das neurofibromatoses, é genodermatose transmitida segundo padrão mendeliano autossómico dominante. O diagnóstico de NF1 assenta em critérios diagnósticos, entre os quais as alterações cutâneas, oculares e esqueléticas são as mais relevantes, embora múltiplas neoplasias envolvendo diversos orgãos e sistemas não possam ser esquecidas ou sub-valorizadas já que é bem conhecido que o produto genético do gene alterado da NF1 – a neurofibromina – é uma proteina de supressão tumoral. Feocromocitomas ocorrem em menos de 1% dos doentes com NF1; por outro lado, apenas 5% dos casos reportados de feocromocitoma estão associados com a NF I. No entanto, entre doentes hipertensos com NF1, a prevalência de feocromocitoma pode atingir os 50%.Caso clínico: É relatado caso de eurocaucasiana de 27 A de idade, com diagnóstico de NF1 com história de 4 meses de cólicas abdominais, hiperhidrose generalizada, dispneia e hipertensão arterial paroxística. As catecolaminas e metanefrinas urinárias estavam aumentadas e a exploração topográfica levada a cabo (RMN e I-MIBG) permitiram detectar uma massa na glândula suprarrenal direita, a qual, após adrenalectomia confirmou o diagnóstico de feocromocitoma. Conclusão: O caso apresentado enfatiza a necessidade de uma abordagem multissistémica, multidisciplinar a doentes com NF1, tendo em conta as manifestações sistémicas associadas, na base de um prognóstico por vezes fechado da doença.
The aim of this study was to evaluate the use of antibiotics in cows during the dry period. The survey was performed on 148 teats during the dry period, with sample collection in the period D-70 (70 days before delivery) and D14 (14 days after delivery). The milk samples were collected for the Strip Cup Test (SCT), California Mastitis Test (CMT), Microbiological Culture, Somatic Cell Count (SCC), Somatic Cell Score (SCS) and Hyperkeratosis (HK). The groups in which there were no microorganisms grow were divided into two groups, in the first group only the internal sealant in the teat was used (Group 1) and there was another group with the intramammary antibiotic use associated with the internal sealant (Group 2). Teats which were considered positive, with microbiological growth, were treated with the intramammary antibiotic associated with the internal sealant (Group 3). In the comparison of the results of the CMT test between D-70 and D14, a statistical difference was observed in Groups 2 and 3. Group 3, which comprises the positive teats in D-70 presented a reduction of 83.87% and 32.26% in the CMT test between D-70 and D14. Regarding HK, group 1 and 2 had a statistical difference in relation to group 3 in D-70 and D14. As for the numbers of bacteria isolated in D-70 and D14, there was no difference comparing Group 1 and Group 2, unlike Group 3, which had a difference. Group 1 and Group 2 were all negative teats in D-70, showing that the intramammary antibiotic did not influence the outcome of D14. In group 3 there was a reduction of isolates from 62 to 15 in D14. The most prevalent microorganism was Streptococcus agalactiae with 43.37% of the total isolates, followed by Staphylococcus aureus (16.87%) and Corynebacterium spp. (13.25%) and Coagulase negative Staphylococcus (SCN) (10.84%). The selective treatment of teats in dry dairy cows has advantages over Blanket Dry Cow Therapy by reducing the indiscriminate use of antibiotics, avoiding bacterial resistance, ensuring better milk quality and greater food safety. Antibiotics should only be used for teats with subclinical mastitis, with the microbiological culture at the end of lactation performed by fourth individual mammary.
Este tutorial esta disponível em vídeo https://www.youtube.com/watch?v=hgAOoBdjsCo&t=1s.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.